144 related articles for article (PubMed ID: 35004113)
1. Vonoprazan-associated long QT syndrome.
Kubo K; Sakakibara T; Yonezawa K; Kato M
J Gen Fam Med; 2022 Jan; 23(1):54-55. PubMed ID: 35004113
[TBL] [Abstract][Full Text] [Related]
2. Vonoprazan-associated Gastric Mucosal Redness: A Report of Four Cases.
Kubo K; Kimura N; Matsuda S; Tsuda M; Mabe K; Kato M
Intern Med; 2020 Feb; 59(4):507-511. PubMed ID: 31611534
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy and Reversible Drug Induced QT Prolongation in a Patient with Advanced Cancer: Case Report.
Cerdà G; Julià-Torras J; González-Barboteo J; Romeo M; Calsina-Berna A
J Pain Palliat Care Pharmacother; 2024 Mar; 38(1):33-37. PubMed ID: 38180376
[TBL] [Abstract][Full Text] [Related]
4. Vonoprazan-Associated Gastric Mucosal Redness in Non-
Kubo K; Kimura N; Watanabe R; Higashino M; Tsuda M; Kato M
Case Rep Gastroenterol; 2021; 15(2):751-758. PubMed ID: 34594176
[TBL] [Abstract][Full Text] [Related]
5. Effect of Antibiotic Susceptibility and
Sugimoto M; Hira D; Murata M; Kawai T; Terada T
Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 32993151
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel.
Nishihara M; Yamasaki H; Czerniak R; Jenkins H
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):217-227. PubMed ID: 30361928
[TBL] [Abstract][Full Text] [Related]
7. Drug- and non-drug-associated QT interval prolongation.
van Noord C; Eijgelsheim M; Stricker BH
Br J Clin Pharmacol; 2010 Jul; 70(1):16-23. PubMed ID: 20642543
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
Okuyama M; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
Digestion; 2017; 95(4):281-287. PubMed ID: 28501868
[TBL] [Abstract][Full Text] [Related]
9. Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib
Zhou S; Zhao FL; Wang SH; Wang YR; Hong Y; Zhou Q; Geng PW; Luo QF; Cai JP; Dai DP
Pharm Biol; 2023 Dec; 61(1):356-361. PubMed ID: 36728978
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan
Wang Y; Wang C; Wang S; Zhou Q; Dai D; Shi J; Xu X; Luo Q
Front Pharmacol; 2020; 11():53. PubMed ID: 32116727
[TBL] [Abstract][Full Text] [Related]
11. Effects of Vonoprazan on the Antiplatelet Function of Prasugrel Assessed by the VerifyNow P2Y
Koga S; Ikeda S; Akashi R; Yonekura T; Kawano H; Maemura K
Circ Rep; 2020 Dec; 3(1):26-33. PubMed ID: 33693287
[No Abstract] [Full Text] [Related]
12. Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism
Wang Y; Shi J; Dai D; Cai J; Wang S; Hong Y; Zhou S; Zhao F; Zhou Q; Geng P; Zhou Y; Xu X; Luo Q
Front Pharmacol; 2022; 13():909168. PubMed ID: 36052128
[TBL] [Abstract][Full Text] [Related]
13. Long-term potassium-competitive acid blockers administration causes microbiota changes in rats.
Najah H; Edelmuth RCL; Riascos MC; Grier A; Al Asadi H; Greenberg JA; Miranda I; Crawford CV; Finnerty BM; Fahey TJ; Zarnegar R
Surg Endosc; 2023 Oct; 37(10):7980-7990. PubMed ID: 37452210
[TBL] [Abstract][Full Text] [Related]
14. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.
Ehret GB; Desmeules JA; Broers B
Expert Opin Drug Saf; 2007 May; 6(3):289-303. PubMed ID: 17480178
[TBL] [Abstract][Full Text] [Related]
15. Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data.
Marabotto E; Ziola S; Savarino V; Giannini EG; Furnari M; Bodini G; Zingone F; Ghisa M; Barberio B; Zentilin P; Savarino E
Clin Exp Gastroenterol; 2020; 13():99-104. PubMed ID: 32346304
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Risk Assessment Among Older Patients with Polypharmacy Using the Clinical Decision Support System Janusmed Risk Profile: A Cross-Sectional Register Study.
Petersson L; Schörgenhofer C; Askfors Y; Justad H; Dahl ML; Andersson ML
Drugs Aging; 2023 Apr; 40(4):369-376. PubMed ID: 37039960
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose.
Berling I; Hatten BW; Hoffman RS; Othong R; Roberts DM; Mustafa RA; Yates C; Cormier M; Gosselin S
Clin Toxicol (Phila); 2020 Jan; 58(1):20-28. PubMed ID: 31018700
[No Abstract] [Full Text] [Related]
18. Vonoprazan-based therapy for
Akazawa Y; Fukuda D; Fukuda Y
Therap Adv Gastroenterol; 2016 Nov; 9(6):845-852. PubMed ID: 27803739
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin-induced proarrhythmia and cardiovascular death.
Howard PA
Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
[TBL] [Abstract][Full Text] [Related]
20. Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis.
Xu W; Bai Z; Shang Y; Wang J; Wong Y; Qi X
Therap Adv Gastroenterol; 2023; 16():17562848231167858. PubMed ID: 37113190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
